SCHEMBL1811537

SCHEMBL1811537

O=C(O)Cc1c(F)cccc1I

nearest known ligand 0.47

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
AKR1B1 P15121 2/20 0.47
PTGS2 P35354 3/20 0.47
KDM4E B2RXH2 1/20 0.42
CXCL8 P10145 2/20 0.41
PTGS1 P23219 2/20 0.39
CES2 O00748 1/20 0.39
CES1 P23141 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
KMT2A Q03164 3/20 0.37
MEN1 O00255 2/20 0.37
ALDH1A1 P00352 2/20 0.37
HPGD P15428 1/20 0.37
NPC1 O15118 1/20 0.37
POLB P06746 1/20 0.37
MAPT P10636 1/20 0.37
ALB P02768 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL503912 0.86 AKR1B1 (0.56) AKR1B1PTGS2KDM4ECXCL8PTGS1
Hydrochloric Acid SCHEMBL1372001 0.84 AKR1B1 (0.54) AKR1B1PTGS2KDM4ECXCL8PTGS1
SCHEMBL28795881 0.79 TAAR1 (0.39) PTGS2KDM4ECES2CES1TDP1
SCHEMBL289780 0.78 AKR1B1 (0.50) AKR1B1PTGS2KDM4ECXCL8PTGS1
SCHEMBL29101389 0.77 KDM4E (0.50) AKR1B1PTGS2KDM4EKMT2AMEN1
SCHEMBL1626950 0.77 AKR1B1 (0.74) AKR1B1PTGS2KDM4ECXCL8PTGS1
SCHEMBL29570152 0.77 AKR1B1 (0.74) AKR1B1KDM4EKMT2AMEN1ALDH1A1
SCHEMBL3827697 0.77 AKR1B1 (0.47) AKR1B1PTGS2KDM4ECXCL8PTGS1
SCHEMBL28153560 0.77 KDM4E (0.50) AKR1B1PTGS2KDM4ECXCL8KMT2A
SCHEMBL1285811 0.77 AKR1B1 (0.74) AKR1B1KDM4EKMT2AMEN1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2803267-A1 COMPOSITION FOR CONTROLLING PLANT DISEASE AND APPLICATION THEREOF Sumitomo Chemical Company Limited (JP) 2014-11-19 EP disclosed
EP-2493303-A1 2- [1-PHENYL-5-HYDROXY-4a-SUBSTITUTED-HEXAHYDROCYCLOPENTA [F]INDAZOL-5-YL]ETHYL PHENYL DERIVATIVES AS GLUCOCORTICOID RECEPTOR LIGANDS Merck Sharp & Dohme Corp. (US) 2012-09-05 EP disclosed
US-20120214847-A1 2-[1-PHENYL-5-HYDROXY-4a-SUBSTITUTED-HEXAHYDROCYCLOPENTA[F]INDAZOL-5-YL]ETHYL PHENYL DERIVATIVES AS GLUCOCORTICOID RECEPTOR LIGANDS MERCK SHARP & DOHME CORP. (US) 2012-08-23 US disclosed
US-20120214847-A1 2-[1-PHENYL-5-HYDROXY-4a-SUBSTITUTED-HEXAHYDROCYCLOPENTA[F]INDAZOL-5-YL]ETHYL PHENYL DERIVATIVES AS GLUCOCORTICOID RECEPTOR LIGANDS MERCK SHARP & DOHME CORP. (US) 2012-08-23 US disclosed
US-20120214847-A1 2-[1-PHENYL-5-HYDROXY-4a-SUBSTITUTED-HEXAHYDROCYCLOPENTA[F]INDAZOL-5-YL]ETHYL PHENYL DERIVATIVES AS GLUCOCORTICOID RECEPTOR LIGANDS MERCK SHARP & DOHME CORP. (US) 2012-08-23 US disclosed
WO-2011053574-A1 2- [1-PHENYL-5-HYDROXY-4a-SUBSTITUTED-HEXAHYDROCYCLOPENTA [F] INDAZOL-5-YL] ETHYL PHENYL DERIVATIVES AS GLUCOCORTICOID RECEPTOR LIGANDS MERCK SHARP & DOHME CORP. (US) 2011-05-05 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120214847-A1 2-[1-PHENYL-5-HYDROXY-4a-SUBSTITUTED-HEXAHYDROCYCLOPENTA[F]INDAZOL-5-YL]ETHYL PHENYL DERIVATIVES AS GLUCOCORTICOID RECEPTOR LIGANDS NR3C1, NR3C2, NR5A1 AKR1B1 321/4885PTGS2 395/4885KDM4E 2489/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.